Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
110.05
-0.72 (-0.65%)
At close: Jan 23, 2026, 4:00 PM EST
110.10
+0.05 (0.05%)
After-hours: Jan 23, 2026, 5:46 PM EST
Celcuity Market Cap
Celcuity has a market cap or net worth of $5.09 billion as of January 23, 2026. Its market cap has increased by 941.34% in one year.
Market Cap
5.09B
Enterprise Value
4.96B
1-Year Change
941.34%
Ranking
Category
Stock Price
$110.05
Market Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $5.09B, an increase of 3,702.95%. That is a compound annual growth rate of 54.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 5.13B | 11.06% |
| Dec 31, 2025 | 4.62B | 849.61% |
| Dec 31, 2024 | 486.00M | 37.83% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
| Sep 20, 2017 | 133.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 5.45B |
| Immunovant | 5.30B |
| Protagonist Therapeutics | 5.22B |
| CRISPR Therapeutics AG | 5.01B |
| Mirum Pharmaceuticals | 4.75B |
| Scholar Rock Holding | 4.56B |
| TG Therapeutics | 4.52B |
| ACADIA Pharmaceuticals | 4.45B |